Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
U.S. stocks were lower, with the Nasdaq Composite falling more than 100 points on Thursday.
Barclays analyst Gena Wang upgrades Kodiak Sciences (NASDAQ: KOD) from Underweight to Equal-Weight and raises the price targ...
Jefferies analyst Maury Raycroft initiates coverage on Kodiak Sciences (NASDAQ:KOD) with a Buy rating and announces Price Ta...
Meaningful vision gains are rapidly achieved as early as week 4 and more than half of patients in the top two dose levels impro...
Kodiak Sciences posted a second-quarter loss of $1.03 per share, compared to market estimates of a loss of $1.02 per share.
HC Wainwright & Co. analyst Matthew Caufield maintains Kodiak Sciences (NASDAQ:KOD) with a Neutral and raises the price ...
